SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-087613
Filing Date
2016-01-04
Accepted
2016-01-04 08:45:25
Documents
3
Period of Report
2015-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-25719_18k.htm 8-K 46035
2 EX-99.1 a15-25719_1ex99d1.htm EX-99.1 15547
3 GRAPHIC g257191mmi001.jpg GRAPHIC 2940
  Complete submission text file 0001104659-16-087613.txt   67179
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 161316519
SIC: 2836 Biological Products, (No Diagnostic Substances)